<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p15" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_15{left:130px;bottom:1195px;letter-spacing:0.23px;}
#t2_15{left:804px;bottom:1195px;letter-spacing:0.13px;}
#t3_15{left:128px;bottom:1095px;letter-spacing:-0.21px;}
#t4_15{left:238px;bottom:1096px;letter-spacing:-0.01px;}
#t5_15{left:128px;bottom:1042px;letter-spacing:0.16px;}
#t6_15{left:238px;bottom:1042px;letter-spacing:-0.2px;}
#t7_15{left:128px;bottom:994px;letter-spacing:-0.18px;}
#t8_15{left:238px;bottom:994px;letter-spacing:-0.21px;}
#t9_15{left:238px;bottom:965px;letter-spacing:-0.01px;}
#ta_15{left:238px;bottom:946px;letter-spacing:-0.01px;}
#tb_15{left:238px;bottom:926px;letter-spacing:-0.01px;}
#tc_15{left:238px;bottom:907px;letter-spacing:-0.01px;}
#td_15{left:238px;bottom:853px;letter-spacing:-0.01px;}
#te_15{left:238px;bottom:833px;letter-spacing:-0.01px;}
#tf_15{left:238px;bottom:814px;letter-spacing:-0.01px;}
#tg_15{left:238px;bottom:794px;letter-spacing:-0.01px;}
#th_15{left:238px;bottom:775px;letter-spacing:-0.01px;}
#ti_15{left:238px;bottom:756px;letter-spacing:-0.01px;}
#tj_15{left:238px;bottom:736px;letter-spacing:-0.01px;}
#tk_15{left:238px;bottom:717px;letter-spacing:-0.01px;}
#tl_15{left:238px;bottom:697px;letter-spacing:-0.01px;}
#tm_15{left:238px;bottom:604px;letter-spacing:0.1px;}
#tn_15{left:238px;bottom:570px;letter-spacing:-0.01px;}
#to_15{left:238px;bottom:550px;letter-spacing:-0.01px;}
#tp_15{left:238px;bottom:515px;letter-spacing:-0.01px;}
#tq_15{left:238px;bottom:496px;letter-spacing:-0.01px;}
#tr_15{left:238px;bottom:477px;letter-spacing:-0.01px;}
#ts_15{left:238px;bottom:457px;letter-spacing:-0.01px;}
#tt_15{left:238px;bottom:438px;letter-spacing:-0.01px;}
#tu_15{left:238px;bottom:403px;letter-spacing:-0.01px;}
#tv_15{left:238px;bottom:384px;letter-spacing:-0.01px;}
#tw_15{left:238px;bottom:349px;letter-spacing:-0.01px;}
#tx_15{left:238px;bottom:329px;letter-spacing:-0.01px;}
#ty_15{left:238px;bottom:295px;letter-spacing:-0.01px;}
#tz_15{left:238px;bottom:275px;letter-spacing:-0.01px;}
#t10_15{left:238px;bottom:221px;letter-spacing:-0.01px;}
#t11_15{left:238px;bottom:202px;letter-spacing:-0.01px;}
#t12_15{left:238px;bottom:167px;letter-spacing:-0.01px;}
#t13_15{left:238px;bottom:148px;letter-spacing:-0.01px;}
#t14_15{left:238px;bottom:128px;letter-spacing:-0.01px;}
#t15_15{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_15{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_15{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_15{font-size:28px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_15{font-size:26px;font-family:NotoSans-Regular_7j-;color:#000;}
.s4_15{font-size:21px;font-family:NotoSans-Regular_7j-;color:#000;}
.s5_15{font-size:18px;font-family:NotoSans-Regular_7j-;color:#000;}
.s6_15{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts15" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg15Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg15" style="-webkit-user-select: none;"><object width="908" height="1286" data="15/15.svg" type="image/svg+xml" id="pdf15" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_15" class="t s0_15">2.1 Scope and purpose </span><span id="t2_15" class="t s1_15">15 </span>
<span id="t3_15" class="t s2_15">2. </span><span id="t4_15" class="t s3_15">introduction </span>
<span id="t5_15" class="t s4_15">2.1. </span><span id="t6_15" class="t s4_15">Scope and purpose </span>
<span id="t7_15" class="t s5_15">2.1.1. </span><span id="t8_15" class="t s5_15">Objectives and questions </span>
<span id="t9_15" class="t s6_15">Laryngeal carcinoma is the third most common type of cancer in the head and neck region. It </span>
<span id="ta_15" class="t s6_15">occurs primarily in men, who are affected 7 times more often than women. The peak age is </span>
<span id="tb_15" class="t s6_15">between 50 and 70 years. In Germany, around 3,600 men and 500 women develop laryngeal </span>
<span id="tc_15" class="t s6_15">carcinoma every year (www.rki.de). The majority of these are squamous cell carcinomas. </span>
<span id="td_15" class="t s6_15">Therapeutic results can be improved through early detection. Suitable methods for this, such as </span>
<span id="te_15" class="t s6_15">electronic chromoendoscopy (narrow band imaging) and other measures are presented in the </span>
<span id="tf_15" class="t s6_15">guideline. In addition to the surgical treatment that is preferred today, conservative, organ- </span>
<span id="tg_15" class="t s6_15">preserving procedures (radiochemotherapy) are also used as primary and adjuvant procedures. </span>
<span id="th_15" class="t s6_15">The decision on a treatment method that is tailored to the specific situation is still very different. </span>
<span id="ti_15" class="t s6_15">The guideline is intended to help improve decision-making regarding the optimal treatment for </span>
<span id="tj_15" class="t s6_15">individual cases (tumor stage, general condition and patient wishes) in the case of laryngeal </span>
<span id="tk_15" class="t s6_15">carcinoma. The guideline is also intended to make decision-making when determining adjuvant </span>
<span id="tl_15" class="t s6_15">therapy easier and to bring it closer to standardization. </span>
<span id="tm_15" class="t s1_15">Target orientation of the guideline </span>
<span id="tn_15" class="t s6_15">The guideline is intended to generally reflect the interdisciplinary nature of early </span>
<span id="to_15" class="t s6_15">detection, diagnosis, therapy, rehabilitation and aftercare. </span>
<span id="tp_15" class="t s6_15">The guideline recommends evidence-based diagnostic and especially therapeutic </span>
<span id="tq_15" class="t s6_15">procedures with the primary goal of organ preservation, but also highlights their </span>
<span id="tr_15" class="t s6_15">limitations. Furthermore, measures for the early detection of laryngeal carcinoma have </span>
<span id="ts_15" class="t s6_15">been developed. Another topic is functional rehabilitation after the treatment of laryngeal </span>
<span id="tt_15" class="t s6_15">carcinoma. </span>
<span id="tu_15" class="t s6_15">In addition, therapy recommendations for treating the lymphatic drainage pathways are </span>
<span id="tv_15" class="t s6_15">given. Finally, concepts of palliative treatment are conveyed. </span>
<span id="tw_15" class="t s6_15">The guideline also includes recommendations for the follow-up care of patients with </span>
<span id="tx_15" class="t s6_15">laryngeal carcinoma. </span>
<span id="ty_15" class="t s6_15">The guideline is intended to provide reliable support in achieving therapeutic goals and to </span>
<span id="tz_15" class="t s6_15">help reduce the frequency of avoidable complications. </span>
<span id="t10_15" class="t s6_15">The guideline is intended to provide patients and relatives with understandable and </span>
<span id="t11_15" class="t s6_15">comprehensible information about the relevant therapy concepts. </span>
<span id="t12_15" class="t s6_15">The recommendations of the guideline for optimal and standardized diagnosis, including </span>
<span id="t13_15" class="t s6_15">appropriate measures for early detection, could be expected to enable patients with carcinoma </span>
<span id="t14_15" class="t s6_15">of the larynx to receive treatment at an earlier stage and thus have a better prognosis. </span>
<span id="t15_15" class="t s0_15">Â© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
